| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| ABSK021 Food Effect Study in Healthy Subjects (NCT05280483) | Abbisko Therapeutics Co, Ltd | 2022-07-23 |
| The Families Addressing Cancer Together Intervention for Parents With Cancer (NCT05377749) | UNC Lineberger Comprehensive Cancer Center | 2022-07-05 |
| CD155 Expression in Acute Myeloid Leukemia (NCT06369662) | Assiut University | 2022-07-01 |
| Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer (NCT05235750) | University of Arkansas | 2022-05-27 |
| Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants (NCT05347979) | Corcept Therapeutics | 2022-05-25 |
| Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality (NCT05918536) | Regina Elena Cancer Institute | 2022-05-17 |
| Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms (NCT05475106) | Instituto de Medicina Regenerativa | 2022-05-12 |
| Lymphaticovenous Anastomosis as Treatment for Lymphedema (NCT05441943) | Odense University Hospital | 2022-05-11 |
| Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts (NCT05442151) | Tadashi Watabe | 2022-05-09 |
| A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor (NCT05298683) | Hellenic Society of Hematology | 2022-05-01 |
| AI Guidance for Biopsy in Suspected Cholangiocarcinoma (NCT05374122) | Instituto Ecuatoriano de Enfermedades Digestivas | 2022-05-01 |
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (NCT05150236) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2022-04-29 |
| A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible (NCT05280275) | Hellenic Society of Hematology | 2022-04-13 |
| Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging (NCT04721756) | Avid Radiopharmaceuticals | 2022-04-12 |
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (NCT04493632) | OncoSil Medical Limited | 2022-04-12 |
| Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms (NCT05307367) | University of Copenhagen | 2022-04-01 |
| A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment (NCT05147493) | Hellenic Society of Hematology | 2022-04-01 |
| Retrospective Analysis of Colorectal Cancer Screening Results (NCT05374369) | Creative Biosciences (Guangzhou) Co., Ltd. | 2022-03-29 |
| First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors (NCT05277051) | GlaxoSmithKline | 2022-03-22 |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) (NCT05103358) | Aadi Bioscience, Inc. | 2022-02-15 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT05160168) | Theseus Pharmaceuticals | 2022-01-03 |
| Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma (NCT05155215) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-12-31 |
| Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials (NCT05100316) | GlaxoSmithKline | 2021-12-16 |
| Mirtazapine in Cancer-related Poly-symptomatology (NCT04763135) | Hospices Civils de Lyon | 2021-12-15 |
| Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy (NCT05022667) | University of Michigan | 2021-12-01 |
| An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C) (NCT05112965) | Hoffmann-La Roche | 2021-12-01 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
| Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings (NCT04931251) | UNC Lineberger Comprehensive Cancer Center | 2021-11-11 |
| The Effect of a Fasting MimickINg Diet on the Immune System (NCT04833439) | Leiden University Medical Center | 2021-11-01 |
| A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors (NCT04991740) | Janssen Research & Development, LLC | 2021-10-24 |
| EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers (NCT05176665) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2021-10-21 |
| A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer (NCT04958239) | Boehringer Ingelheim | 2021-10-18 |
| A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors (NCT04991506) | Elpiscience Biopharma, Ltd. | 2021-10-15 |
| Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) (NCT05066139) | Centre Paul Strauss | 2021-09-17 |
| VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK (NCT04853303) | The Hong Kong Polytechnic University | 2021-09-01 |
| AnovaOS Network Powered Patient Registry (NCT05013944) | Anova Enterprises, Inc | 2021-09-01 |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor (NCT04964375) | Abbisko Therapeutics Co, Ltd | 2021-08-31 |
| 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical (NCT04831307) | British Columbia Cancer Agency | 2021-08-30 |
| Dose Efficiency of Modern CT Scanners in Oncologic Scans (NCT04989192) | University Hospital Augsburg | 2021-08-17 |
| Oral Symptom Assessment Scale (OSAS): Validity and Reliability (NCT04932317) | Our Lady's Hospice and Care Services | 2021-08-05 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| Smart Living Homes: GATEKEEPER System With Patients With Cancer and Dementia in Cyprus (NCT05490524) | Cyprus University of Technology | 2021-06-01 |
| Molecular Disease Characterization Initiative (MDCI) (NCT04772053) | GlaxoSmithKline | 2021-05-25 |
| Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282) | Sociedad Española de Medicina Nuclear e Imagen Molecular | 2021-05-10 |
| Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers (NCT05860530) | Qilu Pharmaceutical Co., Ltd. | 2021-05-10 |
| High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy (NCT04461509) | Alessandro D'Agnolo | 2021-04-06 |
| Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction (NCT06801405) | Barretos Cancer Hospital | 2021-04-02 |
| A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors (NCT04730843) | Elpiscience Biopharma, Ltd. | 2021-04-01 |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors (NCT04673942) | EpicentRx, Inc. | 2021-03-29 |
| Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer (NCT05912062) | Institut Català d'Oncologia | 2021-03-22 |
| BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment (NCT04932863) | Ente Ospedaliero Ospedali Galliera | 2021-03-15 |
| CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood (NCT04811846) | University Teaching Hospital Hall in Tirol | 2021-03-14 |
| Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer (NCT06048705) | Adaptimmune | 2021-03-09 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 (NCT06790303) | GlaxoSmithKline | 2021-03-04 |
| Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study (NCT04991805) | AstraZeneca | 2021-02-26 |
| Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer (NCT04724460) | Takeshi Morimoto | 2021-02-18 |
| Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors (NCT04787003) | North China Petroleum Bureau General Hospital | 2021-02-16 |
| PC001- A Study to Evaluate the Usability of PointCheck (NCT04448301) | Leuko Labs, Inc. | 2021-02-09 |
| Blood Cell RNA-Based Cancer Detection (NCT05839834) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-02-08 |
| Intermittent Fasting and CLL/SLL (NCT04626843) | Eleah Stringer | 2021-02-03 |
| Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer (NCT04706676) | Rigshospitalet, Denmark | 2021-01-26 |
| A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China (NCT04722055) | Creative Biosciences (Guangzhou) Co., Ltd. | 2021-01-26 |
| Information Needs Around Parenteral nUTrition in Cancer (NCT04495530) | Royal Marsden NHS Foundation Trust | 2021-01-19 |
| Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy (NCT04746729) | Institut National de la Santé Et de la Recherche Médicale, France | 2021-01-11 |
| Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer (NCT04596150) | CytomX Therapeutics | 2020-12-29 |
| Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors (NCT04526509) | Adaptimmune | 2020-12-21 |
| Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma (NCT05943990) | Adaptimmune | 2020-12-21 |
| Anticoagulation in Patients With Venous Thromboembolism and Cancer (NCT04618913) | Pfizer | 2020-12-14 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients (NCT04604158) | Gillian Gresham | 2020-12-02 |
| Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. (NCT04388033) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-12-01 |
| External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446) | Blueprint Medicines Corporation | 2020-12-01 |
| Mobile Sensor Technologies to Assess General Symptomology of People With Cancer (NCT04465214) | National Cancer Institute (NCI) | 2020-11-23 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation (NCT04141449) | Brigham and Women's Hospital | 2020-11-18 |
| A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies (NCT04606381) | Janssen Research & Development, LLC | 2020-11-10 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases (NCT05322486) | State Scientific Centre of Coloproctology, Russian Federation | 2020-10-29 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain (NCT04442425) | National Cancer Institute (NCI) | 2020-10-27 |
| A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer (NCT04349280) | GlaxoSmithKline | 2020-10-15 |
| Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) (NCT04544995) | GlaxoSmithKline | 2020-10-06 |
| An Evaluation of the Families Addressing Cancer Together (FACT) Intervention (NCT04342871) | UNC Lineberger Comprehensive Cancer Center | 2020-10-05 |
| Latest Imaging SPECT System Evaluation Phase 1 (NCT04704349) | Centre Hospitalier Régional d'Orléans | 2020-10-05 |
| Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment. (NCT04568278) | Samsung Medical Center | 2020-10-05 |
| A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Ocellaris Pharma, Inc. | 2020-09-24 |
| Multimodal Program for Cancer Related Cachexia Prevention (NCT04627376) | Cyprus University of Technology | 2020-09-24 |
| Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study (NCT05602935) | The Second Affiliated Hospital of Fujian Medical University | 2020-09-16 |
| Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel (NCT04449549) | National Cancer Institute (NCI) | 2020-08-24 |
| ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling (NCT04341181) | Ulrik Lassen | 2020-08-24 |
| A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) (NCT04147234) | Boehringer Ingelheim | 2020-08-03 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients (NCT04446416) | NaviFUS Corporation | 2020-07-21 |
| A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers (NCT04350463) | Celgene | 2020-07-14 |
| A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors (NCT04397276) | Janssen Research & Development, LLC | 2020-07-10 |
| Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt (NCT04300179) | Assiut University | 2020-07-07 |
| Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy (NCT04442724) | Cedars-Sinai Medical Center | 2020-07-01 |
| Clinical Evaluation of a Custom-made and Disposable Endoscope System for Biliary Tract (NCT04456218) | National Cheng-Kung University Hospital | 2020-07-01 |